Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

PEG core cross-linked star-shaped polymer nano-contrast agent and its preparation method and application

A nano-contrast agent and polymer technology, which is applied in the direction of non-active ingredients medical preparations, pharmaceutical formulas, preparations for in vivo tests, etc.

Active Publication Date: 2021-10-29
SHANGHAI TENTH PEOPLES HOSPITAL
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, there is no report about the PEG nuclear cross-linked star-shaped polymer nano-contrast agent used for fundus angiography of the present invention.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PEG core cross-linked star-shaped polymer nano-contrast agent and its preparation method and application
  • PEG core cross-linked star-shaped polymer nano-contrast agent and its preparation method and application
  • PEG core cross-linked star-shaped polymer nano-contrast agent and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1PEG nuclear cross-shaped polymer nanometric film preparation

[0040] Material

[0041] Polyethylene glycol methyl methacrylate (PPEGMA, M n = 300), Sigma-Aldrich, Item No .: 447935; 2-cyano-2-propylodaryyl trikarcarbonate (CTA), Sigma-Aldrich, Item No .: 723037; 1,4-dioxane, Chinese medicine, product number: 10008918; 2,2'-azo bis (2-methylproprionne) (AIBN, CP), Aladdin, Item No.: A104256; 2,2'-azo double (2-methylpropen) ))) Salts (V-50, 97%), Sigma-Aldrich, Item No .: 440914; N, N'-Double (acryl) cystamine (BAC, 98%), Alfa Aesar, Item No .: A-4929 . BN rats were purchased in Beijing Virong Lihua Experimental Animal Technology Co., Ltd., ICR mice were purchased from Shanghai Slack Experimental Animal Co., Ltd. ARPE-19 cell lines from ICELL BIOSCIENCE; human umbilical vein endothelial cells Purchased from Scientll, ICG Amine, purchased from AAT Bioquest, Item No .: 188; Cell Activity Detection Kit (CCK-8) Purchased from Yeasen, Item No .: 40203ES60; Hydrochloride...

Embodiment 2

[0058] Example 2S-PPEGMA 10 -ICG verification of safety and effectiveness of cells and animal levels

[0059] Material, method

[0060] 1.1CCK8 experiment

[0061] Take the several long-term Arpe-19 and huvec cells, laying 96-well plates with 5,000 / well, and placed in the incubator for 24 h, and to be cellular. Add 0-400 nmol / L ICG and S-PPEGMA separately 10 -ICG, incubated 24h. Incubate, each well contains 10 ul CCK-8 medium 110 ul, 37 ° C incubator, and incubation for 2 h. At the end of the detection, the wavelength of 450 nm was selected, and the OD values ​​of each well were detected on the multi-functional enzyme instrument.

[0062] 1.2 Flow cytometry

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a PEG core cross-linked star-shaped macromolecule nano-contrast agent. The contrast agent is a star-shaped macromolecule with PEG as the core and is prepared by bonding a fluorescent group. The invention also relates to the application of the PEG core cross-linked star-shaped macromolecule nano-contrast material in the preparation of fundus vascular contrast agent. Fundus angiography currently used clinically, such as sodium fluorescein or indocyanine green, has adverse reactions when intravenous contrast agents are injected in some patients, and these patients cannot complete the angiography examination. Compared with existing contrast agents, S-PPEGMA of the present invention 10 ‑ICG has the advantages of lower injection concentration and clearer choroid visualization, which can reduce the side effects of the original drug by reducing the administration concentration. In addition, S‑PPEGMA 10 ‑The successful construction of ICG also provides another option for patients who have allergies or other adverse reactions to the injection of existing contrast agents, so that patients can be diagnosed and treated in a timely manner.

Description

Technical field [0001] The present invention relates to the field of fundamental angiography, in particular, is a PEG nuclear cross-strand polymer nano-contrast agent and a preparation method thereof. Background technique [0002] Age-Related Macular Degeneration (AMD) is one of the most important reasons for the central vision of the old people over the age of 50, and there is currently 21 million AMD patients around the world. AMD is divided into dry and wettable based on its non-resinite. Early dry AMD appears to be glass film, and the vision is not serious. It has developed to the late stage, and there will be atrophy in the late stage, and there will be atrophy. Wet AMD, due to the emergence of choroidal neovascularization, CNV), causing bleeding, edema, and severe vision due to hemorrhous bleeding, edema, and vision. At present, the diagnostic methods of AMD include: eye base photography, OCT, fundamental angiography technology, where the eye angiography technology plays an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K49/00A61K47/60
CPCA61K49/0034A61K49/0043A61K49/0054
Inventor 于靖赵鹏蔡雯婷陈起静范佳淇
Owner SHANGHAI TENTH PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com